Cargando…

Serological determinants of COVID-19

BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection spreaded rapidly worldwide, as far as it has become a global pandemic. Therefore, the introduction of serological tests for determination of IgM and IgG antibodies has become the main diagnostic tool, useful for track...

Descripción completa

Detalles Bibliográficos
Autores principales: Noce, Annalisa, Santoro, Maria Luisa, Marrone, Giulia, D’Agostini, Cartesio, Amelio, Ivano, Duggento, Andrea, Tesauro, Manfredi, Di Daniele, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605129/
https://www.ncbi.nlm.nih.gov/pubmed/33138856
http://dx.doi.org/10.1186/s13062-020-00276-1
_version_ 1783604252241821696
author Noce, Annalisa
Santoro, Maria Luisa
Marrone, Giulia
D’Agostini, Cartesio
Amelio, Ivano
Duggento, Andrea
Tesauro, Manfredi
Di Daniele, Nicola
author_facet Noce, Annalisa
Santoro, Maria Luisa
Marrone, Giulia
D’Agostini, Cartesio
Amelio, Ivano
Duggento, Andrea
Tesauro, Manfredi
Di Daniele, Nicola
author_sort Noce, Annalisa
collection PubMed
description BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection spreaded rapidly worldwide, as far as it has become a global pandemic. Therefore, the introduction of serological tests for determination of IgM and IgG antibodies has become the main diagnostic tool, useful for tracking the spread of the virus and for consequently allowing its containment. In our study we compared point of care test (POCT) lateral flow immunoassay (FIA) vs automated chemiluminescent immunoassay (CLIA), in order to assess their specificity and sensibility for COVID-19 antibodies detection. RESULTS: We find that different specificities and sensitivities for IgM and IgG tests. Notably IgM POCT FIA method vs CLIA method (gold standard) has a low sensitivity (0.526), while IgG POCT FIA method vs CLIA method (gold standard) test has a much higher sensitivity (0.937); further, with respect of IgG, FIA and CLIA could arguably provide equivalent information. CONCLUSIONS: FIA method could be helpful in assessing in short time, the possible contagiousness of subjects that for work reasons cannot guarantee “social distancing”.
format Online
Article
Text
id pubmed-7605129
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-76051292020-11-02 Serological determinants of COVID-19 Noce, Annalisa Santoro, Maria Luisa Marrone, Giulia D’Agostini, Cartesio Amelio, Ivano Duggento, Andrea Tesauro, Manfredi Di Daniele, Nicola Biol Direct Research BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection spreaded rapidly worldwide, as far as it has become a global pandemic. Therefore, the introduction of serological tests for determination of IgM and IgG antibodies has become the main diagnostic tool, useful for tracking the spread of the virus and for consequently allowing its containment. In our study we compared point of care test (POCT) lateral flow immunoassay (FIA) vs automated chemiluminescent immunoassay (CLIA), in order to assess their specificity and sensibility for COVID-19 antibodies detection. RESULTS: We find that different specificities and sensitivities for IgM and IgG tests. Notably IgM POCT FIA method vs CLIA method (gold standard) has a low sensitivity (0.526), while IgG POCT FIA method vs CLIA method (gold standard) test has a much higher sensitivity (0.937); further, with respect of IgG, FIA and CLIA could arguably provide equivalent information. CONCLUSIONS: FIA method could be helpful in assessing in short time, the possible contagiousness of subjects that for work reasons cannot guarantee “social distancing”. BioMed Central 2020-11-02 /pmc/articles/PMC7605129/ /pubmed/33138856 http://dx.doi.org/10.1186/s13062-020-00276-1 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Noce, Annalisa
Santoro, Maria Luisa
Marrone, Giulia
D’Agostini, Cartesio
Amelio, Ivano
Duggento, Andrea
Tesauro, Manfredi
Di Daniele, Nicola
Serological determinants of COVID-19
title Serological determinants of COVID-19
title_full Serological determinants of COVID-19
title_fullStr Serological determinants of COVID-19
title_full_unstemmed Serological determinants of COVID-19
title_short Serological determinants of COVID-19
title_sort serological determinants of covid-19
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605129/
https://www.ncbi.nlm.nih.gov/pubmed/33138856
http://dx.doi.org/10.1186/s13062-020-00276-1
work_keys_str_mv AT noceannalisa serologicaldeterminantsofcovid19
AT santoromarialuisa serologicaldeterminantsofcovid19
AT marronegiulia serologicaldeterminantsofcovid19
AT dagostinicartesio serologicaldeterminantsofcovid19
AT amelioivano serologicaldeterminantsofcovid19
AT duggentoandrea serologicaldeterminantsofcovid19
AT tesauromanfredi serologicaldeterminantsofcovid19
AT didanielenicola serologicaldeterminantsofcovid19